Antitumor agents that effectively inhibited the expression of at least two identified significant genes in GBM cell lines were nutlin-3a, cabozantinib, fedratinib, NVP-BHG712, and MIM1 (Figure 4). The gene discussed is MIMT1; the disease is glioblastoma.